Intravenous tranexamic acid as an adjunct haemostat to ornipressin during open myomectomy. A randomized double blind placebo controlled trial

Sammy Ngichabe; Timona Obura; William Stones

doi:10.1186/s13022-015-0017-y

Intravenous tranexamic acid as an adjunct haemostat to ornipressin during open myomectomy. A randomized double blind placebo controlled trial

Sammy Ngichabe, Timona Obura, William Stones

School of Medicine

Research output: Contribution to journal › Article › peer-review

28 Citations (Scopus)

1 Downloads (Pure)

Abstract

Myomectomy is a surgical technique used for removal of uterine fibroids and historically hysterectomy has represented the mainstay of treatment. The options of conservative surgical approaches mainly aim at retention of fertility but have to be balanced against potential risks such as haemorrhage; blood loss at myomectomy still remains troublesome with use of various pharmacologic agents yielding inconclusive results. This trial aimed to explore the benefit of combining ornipressin and tranexamic acid during open myomectomy.

Original language	English
Article number	10
Number of pages	6
Journal	Annals of Surgical Innovation and Research
Volume	9
DOIs	https://doi.org/10.1186/s13022-015-0017-y
Publication status	Published - 31 Oct 2015

Keywords

Haemorrhage
Myomectomy
Tranexamic acid
Ornipressin

Access to Document

10.1186/s13022-015-0017-y

ngichabe2015annsurginnovres10
© 2015 Ngichabe et al. Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Final published version, 1.01 MB

Cite this

@article{124874b136ca43419143547ad1271581,

title = "Intravenous tranexamic acid as an adjunct haemostat to ornipressin during open myomectomy. A randomized double blind placebo controlled trial",

abstract = "Myomectomy is a surgical technique used for removal of uterine fibroids and historically hysterectomy has represented the mainstay of treatment. The options of conservative surgical approaches mainly aim at retention of fertility but have to be balanced against potential risks such as haemorrhage; blood loss at myomectomy still remains troublesome with use of various pharmacologic agents yielding inconclusive results. This trial aimed to explore the benefit of combining ornipressin and tranexamic acid during open myomectomy.",

keywords = "Haemorrhage, Myomectomy, Tranexamic acid, Ornipressin",

author = "Sammy Ngichabe and Timona Obura and William Stones",

year = "2015",

month = oct,

day = "31",

doi = "10.1186/s13022-015-0017-y",

language = "English",

volume = "9",

journal = "Annals of Surgical Innovation and Research",

issn = "1750-1164",

publisher = "BioMed Central",

}

TY - JOUR

T1 - Intravenous tranexamic acid as an adjunct haemostat to ornipressin during open myomectomy. A randomized double blind placebo controlled trial

AU - Ngichabe, Sammy

AU - Obura, Timona

AU - Stones, William

PY - 2015/10/31

Y1 - 2015/10/31

N2 - Myomectomy is a surgical technique used for removal of uterine fibroids and historically hysterectomy has represented the mainstay of treatment. The options of conservative surgical approaches mainly aim at retention of fertility but have to be balanced against potential risks such as haemorrhage; blood loss at myomectomy still remains troublesome with use of various pharmacologic agents yielding inconclusive results. This trial aimed to explore the benefit of combining ornipressin and tranexamic acid during open myomectomy.

AB - Myomectomy is a surgical technique used for removal of uterine fibroids and historically hysterectomy has represented the mainstay of treatment. The options of conservative surgical approaches mainly aim at retention of fertility but have to be balanced against potential risks such as haemorrhage; blood loss at myomectomy still remains troublesome with use of various pharmacologic agents yielding inconclusive results. This trial aimed to explore the benefit of combining ornipressin and tranexamic acid during open myomectomy.

KW - Haemorrhage

KW - Myomectomy

KW - Tranexamic acid

KW - Ornipressin

U2 - 10.1186/s13022-015-0017-y

DO - 10.1186/s13022-015-0017-y

M3 - Article

C2 - 26568770

SN - 1750-1164

VL - 9

JO - Annals of Surgical Innovation and Research

JF - Annals of Surgical Innovation and Research

M1 - 10

ER -

Intravenous tranexamic acid as an adjunct haemostat to ornipressin during open myomectomy. A randomized double blind placebo controlled trial

Abstract

Keywords

Access to Document

Fingerprint

Cite this